Clinical Trial

Health Ahead Comparative Effectiveness Study

Study acronym: HACE
Recruiting
View on ClinicalTrials.gov →
Summary
The Health Ahead Comparative Effectiveness Study is a pragmatic, parallel-arm interventional platform that systematically compares successive changes to preventive health screening - each isolated as a single variable against current practice - on the path toward a fully automated screening system deployable in any environment, including the most isolated and resource-limited communities. Each comparison is evaluated with a common set of engagement, behavior-change, experience, cost, and longitudinal outcome measures, allowing results to accumulate on a consistent yardstick across the life of the platform. The first comparison evaluates static versus interactive personalized health report delivery. Subsequent pre-planned comparisons, added by protocol amendment, evaluate mobile community versus fixed laboratory screening; and a hybrid medical-droid plus human-delivery model versus human-only screening. All participants are simultaneously enrolled in the 100-Year Human Aging Study and the Human Observatory Study, contributing individual longitudinal and population-level causal inference data through those protocols.
Trial Details
NCT Number NCT07669168
Lead Sponsor William Brandenburg, MD
Conditions Health Services Accessibility, Rural Health, Medically Underserved Area, Preventive Health Services, Patient Participation, Health Behavior, Aging, Cardiovascular Diseases +7 more
Enrollment 1,000,000 participants
Start Date 2026-06-09
Primary Completion 2099-12-31 (estimated)
Study Completion 2099-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25